These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17402748)

  • 1. Positive aspects of negative design: simultaneous selection of specificity and interaction stability.
    Mason JM; Müller KM; Arndt KM
    Biochemistry; 2007 Apr; 46(16):4804-14. PubMed ID: 17402748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectional and mutational scope of peptides sequestering the Jun-Fos coiled-coil domain.
    Hagemann UB; Mason JM; Müller KM; Arndt KM
    J Mol Biol; 2008 Aug; 381(1):73-88. PubMed ID: 18586270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPEP: peptides designed and selected for interfering with protein interaction and function.
    Mason JM; M Müller K; Arndt KM
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1442-7. PubMed ID: 19021572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hydrophobic and electrostatic interactions in coiled coil stability and specificity.
    Mason JM; Hagemann UB; Arndt KM
    Biochemistry; 2009 Nov; 48(43):10380-8. PubMed ID: 19743874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrostatic contacts in the activator protein-1 coiled coil enhance stability predominantly by decreasing the unfolding rate.
    Mason JM
    FEBS J; 2009 Dec; 276(24):7305-18. PubMed ID: 20050182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Truncated and helix-constrained peptides with high affinity and specificity for the cFos coiled-coil of AP-1.
    Rao T; Ruiz-Gómez G; Hill TA; Hoang HN; Fairlie DP; Mason JM
    PLoS One; 2013; 8(3):e59415. PubMed ID: 23544065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct selection of antibodies from complex libraries with the protein fragment complementation assay.
    Koch H; Gräfe N; Schiess R; Plückthun A
    J Mol Biol; 2006 Mar; 357(2):427-41. PubMed ID: 16442560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated design of specificity in molecular recognition.
    Havranek JJ; Harbury PB
    Nat Struct Biol; 2003 Jan; 10(1):45-52. PubMed ID: 12459719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved stability of the Jun-Fos Activator Protein-1 coiled coil motif: A stopped-flow circular dichroism kinetic analysis.
    Mason JM; Hagemann UB; Arndt KM
    J Biol Chem; 2007 Aug; 282(32):23015-24. PubMed ID: 17483489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and characterization of Affibody ligands to the transcription factor c-Jun.
    Lundberg E; Brismar H; Gräslund T
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):17-27. PubMed ID: 18260830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic analysis of Jun-Fos coiled coil peptide antagonists.
    Worrall JA; Mason JM
    FEBS J; 2011 Feb; 278(4):663-72. PubMed ID: 21199371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-hybrid fluorescence cross-correlation spectroscopy detects protein-protein interactions in vivo.
    Baudendistel N; Müller G; Waldeck W; Angel P; Langowski J
    Chemphyschem; 2005 May; 6(5):984-90. PubMed ID: 15884086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An object-oriented library for computational protein design.
    Chowdry AB; Reynolds KA; Hanes MS; Voorhies M; Pokala N; Handel TM
    J Comput Chem; 2007 Nov; 28(14):2378-88. PubMed ID: 17471459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-protein interaction analysis by C-terminally specific fluorescence labeling and fluorescence cross-correlation spectroscopy.
    Oyama R; Takashima H; Yonezawa M; Doi N; Miyamoto-Sato E; Kinjo M; Yanagawa H
    Nucleic Acids Res; 2006; 34(14):e102. PubMed ID: 16914444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
    Watt PM
    Nat Biotechnol; 2006 Feb; 24(2):177-83. PubMed ID: 16465163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering novel binding proteins from nonimmunoglobulin domains.
    Binz HK; Amstutz P; Plückthun A
    Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives.
    Shibasaki S; Sakata K; Ishii J; Kondo A; Ueda M
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):735-43. PubMed ID: 18670770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
    Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
    J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downsizing Proto-oncogene cFos to Short Helix-Constrained Peptides That Bind Jun.
    Baxter D; Perry SR; Hill TA; Kok WM; Zaccai NR; Brady RL; Fairlie DP; Mason JM
    ACS Chem Biol; 2017 Aug; 12(8):2051-2061. PubMed ID: 28636317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.